Please wait a minute...
浙江大学学报(医学版)  2017, Vol. 46 Issue (3): 248-255    DOI: 10.3785/j.issn.1008-9292.2017.06.04
出生缺陷预防专题     
浙江省新生儿脂肪酸氧化代谢疾病筛查及随访分析
郑静, 张玉, 洪芳, 杨建滨, 童凡, 毛华庆, 黄晓磊, 周雪莲, 杨茹莱, 赵正言, 黄新文
浙江大学医学院附属儿童医院遗传代谢科 浙江省新生儿疾病筛查中心, 浙江 杭州 310003
Screening for fatty acid oxidation disorders of newborns in Zhejiang province:prevalence, outcome and follow-up
ZHENG Jing, ZHANG Yu, HONG Fang, YANG Jianbin, TONG Fan, MAO Huaqing, HUANG Xiaolei, ZHOU Xuelian, YANG Rulai, ZHAO Zhengyan, HUANG Xinwen
Department of Genetic and Metabolic Diseases, the Children's Hospital, Zhejiang University School of Medicine, Neonatal Screening Center of Zhejiang Province, Hangzhou 310003, China
 全文: PDF(1038 KB)  
摘要:

目的:了解浙江省新生儿脂肪酸氧化代谢类疾病(FAOD)的患病率及预后。方法:收集2009年1月至2016年12月浙江省新生儿疾病筛查中心1 861 262名新生儿资料,采用串联质谱法进行血中游离肉碱和酰基肉碱水平筛查,筛查阳性者进一步通过尿有机酸及相关致病基因突变分析等方法确诊,并对确诊患儿的预后进行分析。结果:在1 861 262名新生儿中确诊七种共121例FAOD患儿,以原发性肉碱吸收障碍(78例,64.5%)最多见,其次为短链酰基辅酶A脱氢酶缺乏症(27例,22.3%),中链酰基辅酶A脱氢酶缺乏症5例(4.1%),多种酰基辅酶A脱氢酶缺乏症4例(3.3%),极长链酰基辅酶A脱氢酶缺乏症3例(2.5%),肉碱棕榈转移酶缺乏症Ⅰ型和Ⅱ型各2例(1.7%)。随访2~82个月,失访15例,死亡4例(原发性肉碱吸收障碍和多种酰基辅酶A脱氢酶缺乏症各1例,肉碱棕榈转移酶缺乏症2例),其余患儿体格和智力均发育正常。结论:FAOD在浙江省新生儿中以原发性肉碱吸收障碍和短链酰基辅酶A脱氢酶缺乏症最常见,通过早期干预管理,多数患儿无临床症状,体格及智力发育正常。

关键词: 线粒体/代谢脂肪酸类/代谢脂质代谢缺陷先天性代谢疾病/代谢氧/代谢串联质谱法新生儿筛查随访研究    
Abstract:

Objective:To screen fatty acid oxidation disorders (FAOD) in newborns in Zhejiang province. Methods:A total of 1 861 262 newborns were screened for FAOD in Neonatal Screening Center of Zhejiang Province during January 2009 and December 2016. The blood samples from newborns were screened by tandem mass spectrometry, and diagnosis of FAOD was confirmed by urine organic acid measurement combined with genetic analysis. The prognosis and follow-up of patients with FAOD were also evaluated. Results:Of 1 861 262 newborns screened, 121 cases of FAOD were diagnosed. Among 121 cases of FAOD, primary carnitine deficiency (PCD) was the most common type (n=78, 64.5%), which was followed by short-chain acyl-CoA dehydrogenase deficiency (SCADD, n=27, 22.3%), medium-chain acyl-CoA dehydrogenase deficiency (n=5, 4.1%), multiple acyl-CoA dehydrogenase deficiency (MADD, n=4, 3.3%), very long-chain acyl-CoA dehydrogenase deficiency (n=3, 2.5%), carnitine palmitoyltransferase Ⅰ deficiency(n=2, 1.7%)and carnitine palmitoyltransferase Ⅱ deficiency (CPTⅡD, n=2, 1.7%). During 2-82 month follow-up, 15 patients were lost, 4 were dead (1 PCD, 1 MADD, and 2 CPTⅡD), and the remaining 102 subjects had normal intelligence and physical development without any clinical symptoms. Conclusions:PCD and SCADD are the most common FAODs in newborns in Zhejiang province. Most of FAOD patients are asymptomatic, and have normal growth and development after early intervention and management.

Key words: Mitochondria/metabolism    Fatty acids/metabolism    Lipid metabolism, inborn errors    Metabolic diseases/metabolism    Oxygen/metabolism    Tandem mass spectrometry    Neonatal screening    Follow-up studies
收稿日期: 2017-02-20 出版日期: 2017-06-25
CLC:  R394  
基金资助:

国家自然科学基金(81172681,81600817);浙江省公益性技术应用研究计划(2016C33148);浙江省医药卫生科技计划(2014KYB142)

通讯作者: 黄新文(1968-),女,博士,主任医师,主要从事遗传代谢病研究;E-mail:6305022@zju.edu.cn     E-mail: 6305022@zju.edu.cn
作者简介: 郑静(1984-),女,博士,助理研究员,主要从事儿童遗传代谢病实验室工作;E-mail:candy88zj@zju.edu.cn
服务  
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章  

引用本文:

郑静 等. 浙江省新生儿脂肪酸氧化代谢疾病筛查及随访分析[J]. 浙江大学学报(医学版), 2017, 46(3): 248-255.

ZHENG Jing, ZHANG Yu, HONG Fang, YANG Jianbin, TONG Fan, MAO Huaqing, HUANG Xiaolei, ZHOU Xuelian, YANG Rulai, ZHAO Zhengyan, HUANG Xinwen. Screening for fatty acid oxidation disorders of newborns in Zhejiang province:prevalence, outcome and follow-up. Journal of ZheJiang University(Medical Science), 2017, 46(3): 248-255.

链接本文:

http://www.zjujournals.com/xueshu/med/CN/10.3785/j.issn.1008-9292.2017.06.04        http://www.zjujournals.com/xueshu/med/CN/Y2017/V46/I3/248

[1] WILCKEN B, WILEY V, HAMMOND J, et al. Screening newborns for inborn errors of metabolism by tandem mass spectrometry[J]. N Engl J Med,2003,348(23):2304-2312.
[2] NIU D M, CHIEN Y H, CHIANG C C, et al. Nationwide survey of extended newborn screening by tandem mass spectrometry in Taiwan[J]. J Inherit Metab Dis,2010,33(Suppl 2):S295-S305.
[3] YAMAGUCHI S. Newborn screening in Japan:restructuring for the new era[J]. Ann Acad Med Singapore,2008,37(12 Suppl):13-15.
[4] FEUCHTBAUM L, CARTER J, DOWRAY S, et al. Birth prevalence of disorders detectable through newborn screening by race/ethnicity[J]. Genet Med,2012,14(11):937-945.
[5] LINDNER M, GRAMER G, HAEGE G, et al. Efficacy and outcome of expanded newborn screening for metabolic diseases-report of 10 years from South-West Germany[J/OL]. Orphanet J Rare Dis,2011,6:44.
[6] LA MARCA G, MALVAGIA S, CASETTA B, et al. Progress in expanded newborn screening for metabolic conditions by LC-MS/MS in Tuscany:update on methods to reduce false tests[J]. J Inherit Metab Dis,2008,31 Suppl 2:S395-S404.
[7] LIM J S,TAN E S, JOHN C M, et al. Inborn Error of Metabolism (IEM) screening in Singapore by electrospray ionization-tandem mass spectrometry (ESI/MS/MS):an 8 year journey from pilot to current program[J]. Mol Genet Metab,2014,113(1-2):53-61.
[8] SELIM L A, HASSAN S A, SALEM F, et al. Selective screening for inborn errors of metabolism by tandem mass spectrometry in Egyptian children:a 5 year report[J]. Clin Biochem,2014,47(9):823-828.
[9] LEE H C, MAK C M, LAM C W, et al. Analysis of inborn errors of metabolism:disease spectrum for expanded newborn screening in Hong Kong[J]. Chin Med J (Engl),2011,124(7):983-989.
[10] YOON H R, LEE K R, KANG S, et al. Screening of newborns and high-risk group of children for inborn metabolic disorders using tandem mass spectrometry in South Korea:a three-year report[J]. Clin Chim Acta,2005,354(1-2):167-180.
[11] ROCHA H, CASTIÑEIRAS D, DELGADO C, et al. Birth prevalence of fatty acid beta-oxidation disorders in Iberia[J]. JIMD Rep,2014,16:89-94.
[12] VILARINHO L, ROCHA H, SOUSA C, et al. Four years of expanded newborn screening in Portugal with tandem mass spectrometry[J]. J Inherit Metab Dis,2010,33 Suppl 3:S133-S138.
[13] LOUKAS Y L, SOUMELAS G S, DOTSIKAS Y, et al. Expanded newborn screening in Greece:30 months of experience[J]. J Inherit Metab Dis,2010,33 Suppl 3:S341-S348.
[14] RASMUSSEN J, NIELSEN O W, JANZEN N, et al. Carnitine levels in 26,462 individuals from the nationwide screening program for primary carnitine deficiency in the Faroe Islands[J]. J Inherit Metab Dis,2014,37(2):215-222.
[15] SCHULZE A, LINDNER M, KOHLMULLER D, et al. Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry:results, outcome, and implications[J]. Pediatrics,2003,111(6 Pt 1):1399-1406.
[16] CHEN Y C, CHIEN Y H, CHEN P W, et al. Carnitine uptake defect (primary carnitine deficiency):risk in genotype-phenotype correlation[J]. Hum Mutat,2013,34(4):655.
[17] BONNEFONT J P, DJOUADI F, PRIP-BUUS C, et al. Carnitine palmitoyltransferases 1 and 2:biochemical, molecular and medical aspects[J]. Mol Aspects Med,2004,25(5-6):495-520.
[18] CHIEN Y H, LEE N C, CHAO M C, et al. Fatty acid oxidation disorders in a chinese population in taiwan[J]. JIMD Rep,2013,11:165-172.
[19] VAN MALDEGEM B T, KLOOSTERMAN S F, JANSSEN W J, et al. High prevalence of short-chain acyl-CoA dehydrogenase deficiency in the Netherlands, but no association with epilepsy of unknown origin in childhood[J]. Neuropediatrics,2011,42(1):13-17.
[20] PENA L, ANGLE B, BURTON B, et al. Follow-up of patients with short-chain acyl-CoA dehydrogenase and isobutyryl-CoA dehydrogenase deficiencies identified through newborn screening:one center's experience[J]. Genet Med,2012,14(3):342-347.
[21] OERTON J, KHALID J M, BESLEY G, et al. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency in England:prevalence, predictive value and test validity based on 1.5 million screened babies[J]. J Med Screen,2011,18(4):173-181.
[22] HARA K, TAJIMA G, OKADA S, et al. Significance of ACADM mutations identified through newborn screening of MCAD deficiency in Japan[J]. Mol Genet Metab,2016,118(1):9-14.
[23] PUREVSUREN J, HASEGAWA Y, FUKUDA S, et al. Clinical and molecular aspects of Japanese children with medium chain acyl-CoA dehydrogenase deficiency[J]. Mol Genet Metab,2012,107(1-2):237-240.
[24] COUCE M L, SÁNCHEZ-PINTOS P, DIOGO L, et al. Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency:regional experience and high incidence of carnitine deficiency[J]. Orphanet J Rare Dis,2013,8:102.
[25] PENA L D, VAN CALCAR S C, HANSEN J, et al. Outcomes and genotype-phenotype correlations in 52 individuals with VLCAD deficiency diagnosed by NBS and enrolled in the IBEM-IS database[J]. Mol Genet Metab,2016,118(4):272-281.
[26] EVANS M, ANDRESEN B S, NATION J, et al. VLCAD deficiency:follow-up and outcome of patients diagnosed through newborn screening in Victoria[J]. Mol Genet Metab,2016,118(4):282-287.
[27] 曹金俊,邱文娟,章瑞南,等.极长链酰基辅酶A脱氢酶缺乏症11例的临床和ACADVL基因突变谱分析[J].中华儿科杂志,2015,53(4):262-267. CAO Jinjun, QIU Wenjuan, ZHANG Ruinan, et al. Clinical features and ACADVL gene mutation spectrum analysis of 11 Chinese patients with long chain acyl-CoA dehydrogenase deficiency[J]. Chinese Journal of Pediatrics,2015,53(4):262-267.(in Chinese)
[28] HAN L, HAN F, YE J, et al. Spectrum analysis of common inherited metabolic diseases in Chinese patients screened and diagnosed by tandem mass spectrometry[J]. J Clin Lab Anal,2015,29(2):162-168.
[29] YAMADA K, KOBAYASHI H, BO R, et al. Clinical, biochemical and molecular investigation of adult-onset glutaric acidemia type Ⅱ:characteristics in comparison with pediatric cases[J]. Brain Dev,2016,38(3):293-301.

[1] 黄新文 等. 浙江省新生儿氨基酸代谢疾病筛查及随访分析[J]. 浙江大学学报(医学版), 2017, 46(3): 233-239.
[2] 李恩书 等. 不同氧浓度培养对体外受精-胚胎移植及子代出生缺陷的影响[J]. 浙江大学学报(医学版), 2017, 46(3): 290-294.
[3] 洪芳 等. 浙江省新生儿有机酸尿症筛查及随访分析[J]. 浙江大学学报(医学版), 2017, 46(3): 240-247.
[4] 朱晖 等. 高龄孕妇外周血胎儿游离DNA产前筛查胎儿常见非整倍体的临床意义[J]. 浙江大学学报(医学版), 2017, 46(3): 256-261.
[5] 严恺 等. 出生缺陷相关遗传病产前诊断技术新进展[J]. 浙江大学学报(医学版), 2017, 46(3): 227-232.
[6] 高秋明 等. Ⅰ期植骨联合非接触钢板技术治疗股骨创伤后感染性骨缺损八例[J]. 浙江大学学报(医学版), 2016, 45(6): 631-635.
[7] 张坚贞, 贺晶. 再发子痫前期相关因素及母子转归的单中心临床研究[J]. 浙江大学学报(医学版), 2015, 44(3): 258-263.
[8] 吕杰敏, 黄迪宇, 林辉, 王先法. 生物补片应用于腹腔镜抗反流手术治疗胃食管反流病疗效观察[J]. 浙江大学学报(医学版), 2015, 44(1): 74-78,84.
[9] 陆洲,裘晓冬,任雅春,等. 缝合锚钉与锁骨钩钢板治疗Neer Ⅱ型锁骨远端骨折临床疗效比较[J]. 浙江大学学报(医学版), 2014, 43(5): 577-.
[10] 徐昕,邓荣欣,邓思敏,等. 三维颌骨模型在髁突外脱位治疗中的应用[J]. 浙江大学学报(医学版), 2014, 43(5): 566-.
[11] 曹培龙,等. 转录因子FOXC1、基质金属蛋白酶7在不同乳腺癌分子亚型中的表达及与临床病理的相关性分析[J]. 浙江大学学报(医学版), 2014, 43(4): 406-412.
[12] 梁黎, 许燕萍. 国内儿科内分泌与遗传代谢病研究进展[J]. 浙江大学学报(医学版), 2013, 42(4): 369-.
[13] . 线粒体钙单向转运体在缺血后处理中对心肌保护的作用[J]. 浙江大学学报(医学版), 2011, 40(3): 304-308.
[14] 蒲朝霞,游向东,王建安. 巨大先天性右房房壁瘤一例[J]. 浙江大学学报(医学版), 2010, 39(5): 550-封3.
[15] 王瑞华. Barrett食管伴有高度不典型增生的内镜诊断和治疗策略[J]. 浙江大学学报(医学版), 2010, 39(5): 534-541.